Neo Spine USA, Inc.
$184.5K 95 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
New York Blood Center, Inc.
New York Blood Center, Inc. reported $184,610.41 across General Payments, Research, and Ownership to 74 physicians and teaching hospitals across 74 transactions.
- $184.6K Below-median payer
- All-tracks total
- 74 Below-median volume
- Transactions
- 74 Below-median reach
- Recipients
- −$27.1K
- General Payments vs PY2023
New York Blood Center, Inc. reported $184,610.41 across all CMS Open Payments tracks (General + Research + Ownership) to 74 physicians and teaching hospitals in Program Year 2024 - ranking #1026 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $184,610.41, averaging $2.5K per recipient.
New York Blood Center, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer new-york-blood-center-inc New York Blood Center, Inc.
$184.6K · #1026/1,925 · 0.0% industry · PY2024
- TOT $184.6K
- RANK #1026
- SHARE 0.0%
- TXN 74
- RCP 74
- CAT 2
- GEN $184.6K
- ΔGEN −$27.1K
- TOP1 75.4%
- PY 2024
Volume peers
Nearest volume peer: Neo Spine USA, Inc. ($184.5K)
New York Blood Center, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
New York Blood Center, Inc.'s CMS-reported General Payments decreased by $27.1K (−12.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: NEW YORK BLOOD CENTER, INC.PY2023: NEW YORK BLOOD CENTER, INC.PY2024: New York Blood Center, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $211,714.66
- PY2024
- $184,610.41
What the Data Shows for New York Blood Center, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For New York Blood Center, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Space Rental or Facility Fees" at $139.4K, accounting for 75.5% of this company's General Payments and 40 transactions.
General Payment Breakdown by Type
New York Blood Center, Inc. made 2 types of general payments. "Space Rental or Facility Fees" is the largest category at $139.4K, 75.5% of General Payments.
How New York Blood Center, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Space Rental or Facility Fees | $139.4K | 40 | 75.5% |
| Compensation for Services Other Than Consulting | $45.2K | 34 | 24.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $184,520.41 (100.0%) of $184,610.41 in this company's General Payments records across 6 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for New York Blood Center, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Christiana Care Health System
$139,151.93 across 37 reported transactions
- 2
Childrens Hosp & Res Cntr Oakland
$14,300.00 across 5 reported transactions
- 3
Dana-Farber Cancer Institute
$12,400.00 across 4 reported transactions
- 4
University Of Minnesota Medical Ctr
$10,028.48 across 12 reported transactions
- 5
Childrens Mercy Hospital
$8,640.00 across 13 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
New York Blood Center, Inc. ranks #1026 of 1,925 by total payments (bottom 47% by spend) but is notably more concentrated than that alone would suggest -- #275 of 1,838 by HHI (top 15% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- TheraMicro, Inc. : $14.0K total payments, HHI 5918
- ReShape Lifesciences Inc. : $5.8K total payments, HHI 5891
- Rebiotix Inc. : $114.1K total payments, HHI 5889
- Spark Therapeutics, Inc. : $1.1M total payments, HHI 5876
- Agile Devices, Inc. : $8.4K total payments, HHI 5847
- Hubly Incorporated : $205.53 total payments, HHI 5839
- New York Blood Center, Inc. (this company) : $184.6K total payments, HHI 5838
- Mylan Pharmaceuticals Inc. : $379.70 total payments, HHI 5777
- Novo Nordisk US Research & Development, Inc. : $7.8K total payments, HHI 5774
- Spinevision SAS : $66.0K total payments, HHI 5765
- Cook Medical LLC : $2.8M total payments, HHI 5718
- Channel Medsystems, Inc. : $194.3K total payments, HHI 5715
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as New York Blood Center, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about New York Blood Center, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with New York Blood Center, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Marius Pharmaceuticals, Inc
$184.4K 23 recipients
Compare payment profiles
RedDress USA, Inc.
$184.0K 225 recipients
Compare payment profiles
Ultrasight Inc
$183.8K 54 recipients
Compare payment profiles
VEO Ophthalmics
$185.8K 0 recipients
Compare payment profiles
Accord Healthcare, Inc.
$183.2K 4,160 recipients
Compare payment profiles
Put this to use
New York Blood Center, Inc. ranks #1026 of 1,925 by all-tracks total payments, led by "Space Rental or Facility Fees".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Space Rental or Facility Fees" spend across every manufacturer, not just New York Blood Center, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.